Academic · Private company
Albert B. Sabin Vaccine Institute
Track this companyFree. Adds Albert B. Sabin Vaccine Institute to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials3
- A Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral Vectored Sudan Ebolavirus Vaccine in Healthy AdultsPHASE2 · ACTIVE_NOT_RECRUITING · started Jun 26, 2025ClinicalTrials.gov NCT06803342 · fetched Nov 12, 2026
- A Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral Vectored Marburg Virus Vaccine in Healthy AdultsPHASE2 · ACTIVE_NOT_RECRUITING · started Apr 14, 2025ClinicalTrials.gov NCT06620003 · fetched Nov 12, 2026
- Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy AdultsPHASE1 · COMPLETED · started Jan 6, 2021ClinicalTrials.gov NCT04723602 · fetched Nov 12, 2026